• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Blocking Axl Protein Shows Promise for Building Stronger Bones

Bioengineer by Bioengineer
July 28, 2026
in Biology
Reading Time: 2 mins read
0
Blocking Axl Protein Shows Promise for Building Stronger Bones
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Osteoporosis steals bone strength over time, leaving millions worldwide more vulnerable to fractures and disability. While today’s therapies can slow loss or stimulate growth, many anabolic options are expensive and often require repeated injections—driving interest in safer, more practical ways to boost the body’s own bone-building machinery.

A new study published online on July 6, 2026, in Bone Research points to an unexpected lever for bone formation: blocking the AXL receptor tyrosine kinase (Axl). Researchers report that inhibiting Axl enhances the maturation and activity of osteoblasts, the cells responsible for generating mineralized bone, resulting in increased bone mass in mice.

To find this pathway, the team ran a kinome-wide RNA interference screen, systematically shutting down protein kinase genes to identify regulators of osteoblast differentiation. Among hundreds of candidates, Axl emerged as a previously underappreciated brake on osteoblast function.

The brake was tested with two strategies. First, the researchers reduced Axl activity using genetic approaches. Second, they applied BGB324, a small-molecule Axl inhibitor. Both approaches produced consistent results: osteoblasts differentiated more effectively and formed more mineralized matrix in lab-based experiments and in animal models.

In mice, BGB324 treatment led to measurable gains in bone mass in long bones and vertebrae. The study also showed an increased number of osteocytes—cells integral to maintaining healthy bone structure—suggesting that Axl inhibition supports broader aspects of bone development rather than merely accelerating early-stage differentiation.

Mechanistically, the work links Axl signaling to interferon-stimulating gene 15 (Isg15). Blocking Axl increased Isg15 activity, which the authors interpret as removal of a molecular restraining signal that normally limits osteoblast maturation and downstream bone-forming programs.

Notably, BGB324 is already being explored in cancer-related clinical contexts because Axl can influence tumor growth and immune regulation. Although this osteoporosis research is still preclinical, the existence of a studied inhibitor could streamline future translational efforts.

The findings position Axl as a promising therapeutic target for anabolic osteoporosis strategies, offering a biologically grounded rationale for developing treatments that encourage the skeleton to rebuild. Further studies will be needed to determine whether this mechanism translates into safe, effective benefits in humans.

News Publication Date: 6-Jul-2026
Article Title: Inhibition of AXL receptor tyrosine kinase increases osteoblast function and bone mass
Web References: http://dx.doi.org/10.1038/s41413-026-00554-0
References: DOI: 10.1038/s41413-026-00554-0
Image Credits: Credit: Dr. Mubashir Ahmad, Dr. Anita Ignatius, and Dr. Jan Tuckermann from Ulm University, Germany
Keywords: osteoporosis; AXL; osteoblast differentiation; BGB324; Isg15; Erk1/2; bone mass; osteocytes; osteoimmunology; receptor tyrosine kinase

Tags: AXL inhibitors for osteoporosisAXL receptor tyrosine kinase inhibitionbone formation enhancementbone health and fracture preventionbone mass increase in micegene silencing in bone researchkinase gene regulation of bone cellsmineralized bone matrix developmentosteoblast maturation and activityOsteoporosis Treatmentpotential new osteoporosis therapiessmall-molecule Axl inhibitors

Share12Tweet7Share2ShareShareShare1

Related Posts

Engineered E. coli Secretes Thermophilic Cellulase Cocktail for Seawater-Compatible Biorefining

Engineered E. coli Secretes Thermophilic Cellulase Cocktail for Seawater-Compatible Biorefining

November 17, 2026
Pregnancy Significantly Alters Pharmacokinetics of Anti-Inflammatory Drug Flunixin in Goats

Pregnancy Significantly Alters Pharmacokinetics of Anti-Inflammatory Drug Flunixin in Goats

November 17, 2026

Experiential Workshop Expands Mexican Students’ Understanding of Bat Diets and Ecological Roles

November 17, 2026

Engineered Escherichia Coli Produces C14-Enriched Lipid Adjuvant Homologs in Bioreactor Batches

November 17, 2026

POPULAR NEWS

  • Digital Twin Framework Preserves Cultural Embroidery Patterns While Reducing Stitch Positioning Errors

    Digital Twin Framework Preserves Cultural Embroidery Patterns While Reducing Stitch Positioning Errors

    29 shares
    Share 12 Tweet 7
  • Post-Jail Intervention Increases Housing Contacts but Does Not Lower Rearrest Rates

    29 shares
    Share 12 Tweet 7
  • Porous Transport Layer Architecture Governs Performance in Anion Exchange Water Electrolysis

    29 shares
    Share 12 Tweet 7
  • FinGPT-Risk Framework Enhances Multi-Task Financial Risk Prediction Across Seven Benchmark Datasets

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Structured IDEA Expert Elicitation Framework Enhances Design of Rare Disease Trials

Syndesmotic Fixation Speeds Early Ankle Recovery but Matches Non-Fixation at Two Years

German Nationwide Survey Identifies Workplace Bullying Patterns Across Industries and Age Groups

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.